You Searched For "keytruda" and got 19 results
Sort By:
1 min read
Moderna soars 24% after the drug maker posts upbeat results from cancer vaccine trial
The pharma giant said combining its cancer vaccine with Merck's Keytruda therapy reduced patients' …
Phil Rosen
4 mins read
We spoke with a key Merck executive about the strategy for its top cancer drug, a $7 billion powerhouse that could soon bring in more than $20 billion
The drugmaker has also tried to reach cancers that haven't responded well to other medicines with c…
Emma Court
3 mins read
A new kind of treatment is working better than chemotherapy in some lung cancer patients
"Immunotherapy with checkpoint inhibitors will displace chemotherapy in yet another subset of patie…
Lydia Ramsey
4 mins read
One crucial quote from Merck CEO Ken Frazier at an event for big-time investors in Manhattan shows the US drug giant at a crossroads
After nearly a decade of leadership by Frazier, Merck is preparing for transition at the top, thoug…
Emma Court
2 mins read
Here's why the drug that helped Jimmy Carter get 'cancer-free' is such a big deal
In someone with melanoma, certain proteins called PD-1 stop the immune system from doing its job an…
Lydia Ramsey
2 mins read
Merck climbs after announcing massive growth for its top cancer drug, which is now on pace to generate $10 billion a year
The bulk of the company's sales win came from Keytruda, a cancer treatment that uses the immune sys…
Ben Winck
2 mins read
2 massive drugmakers are locked in a battle over the market for cancer immunotherapy - Goldman analysts say one is pulling ahead
Last Thursday, Merck announced positive phase 3 results for its treatment of advanced or metastatic…
Charlotte Hu
2 mins read
Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine
The move is welcomed by investors because if successful, it would help Moderna diversify its revenu…
Matthew Fox
2 mins read
There's a major roadblock to one of the most talked about new cancer therapies
It means finding a unique course of treatment that is tailored toward a cancer tumor's particular c…
Lydia Ramsey
3 mins read
Regeneron's coming late to a group of drugs that's already worth billions - here's why the company thinks it can still compete
If it turns out that finding the cancers that are driven by the immune system is key to getting imm…
Lydia Ramsey
5 mins read
'We are going to have lung cancer patients living longer and better:' A new kind of cancer treatment is about to change how we treat the disease
Progression-free survival - a clinical endpoint that basically means the cancer hasn't grown - was …
Lydia Ramsey
5 mins read
Why cancer treatments like the one Jimmy Carter used are suddenly gaining traction
In fact, roughly 30% of metastatic melanoma patients using Keytruda alone respond completely. That'…
Lydia Ramsey
5 mins read
Jimmy Carter is no longer being treated for cancer - Here's why treatments like the one he used are suddenly gaining traction
In fact, roughly 30% of metastatic melanoma patients using Keytruda alone respond completely. That'…
Lydia Ramsey
2 mins read
Bristol-Myers Squibb won't be going after a fast approval for its lung cancer drug
But not everybody responds to the PD-1 drugs. Just a quarter to a third of non-small cell lung canc…
Lydia Ramsey,Reuters
2 mins read
Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough in how we treat the disease
"Now we are an oncology company," Moderna CEO Stéphane Bancel told Insider.
Andrew Dunn
2 mins read
One failed study shows just how fiercely competitive a new field of cancer therapy is
Opdivo, which has already been approved to treat other forms of cancer, has been a big hit for BMS,…
Lydia Ramsey
4 mins read
We're in the middle of a cancer-drug-innovation gold rush - but it has one major side effect
Within immunotherapy, researchers are trying to figure out how to get more people to respond to tre…
Lydia Ramsey
2 mins read
The FDA just took an entirely new approach to approving a cancer drug
On Tuesday, the agency approved pembolizumab (also known as Keytruda) to treat "unresectable or met…
Lydia Ramsey
6 mins read
A new kind of cancer treatment works remarkably well for some patients but not others - and researchers want to know why
But even with this level of excitement, and anecdotal cases like Carter and Schoenbauer, there are …